Program Released | Schistosomiasis Conference 2026
June 2, 2026
Online | Eastern Time (US & Canada)
The II Global Virtual Symposium on Schistosomiasis brings together leading scientists, clinicians, and innovators from around the world to discuss the latest breakthroughs shaping the future of schistosomiasis research and control.
This year’s program highlights cutting-edge advances in vaccine development, host–parasite interactions, immune evasion and immunopathology, molecular diagnostics, clinical trials, fibrosis and disease pathology, drug discovery, and WHO-guided imaging and diagnostic protocols.
From mRNA vaccines, SchistoShield clinical trial updates, and Sm14 vaccine progress in Brazil and Africa, to praziquantel trials in pregnant women and preschool-aged children, the symposium will showcase translational research that is directly influencing global treatment strategies.
Participants will also gain insights into CRISPR-based molecular technologies, parasite metabolism as a therapeutic target, diagnostic accuracy challenges, and novel mechanisms driving schistosome development, immune modulation, and chronic fibrosis.
Takeaways
Emerging vaccine platforms and clinical trial outcomes
New molecular and immunological targets for intervention
Advances in diagnostics and disease monitoring
Evidence-based treatment strategies for vulnerable populations
Future directions for schistosomiasis control and elimination
Join us on June 2, for a day of scientific exchange, collaboration, and innovation in global health.
This conference is organized by Impact Research Communications (IRC)
More info: https://schistosomiasisconference.com/ | Schistosomiasis Research Network
